Yumanity Therapeutics Inc (YMTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Yumanity Therapeutics Inc (YMTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141836FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Yumanity Therapeutics Inc (YMTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Yumanity Therapeutics Inc (Yumanity), formerly known as Proteostasis Therapeutics Inc, is a clinical stage development company focused on the development of treatments for neurodegenerative diseases. The company uses its drug discovery platform for the development of its pipeline products. Yumanity’s pipeline product candidates include YTX-7739 for the treatment of Parkinson’s disease; YTX-9184 for the treatment of dementia with lewy bodies. Other pipeline also comprises of additional programs with undisclosed product candidates that are focused on frontotemporal lobar dementia (FTLD), amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. Yumanity Therapeutics Inc is headquartered in Boston, Massachusetts, the US.

Yumanity Therapeutics Inc Key Recent Developments

Nov 16,2020: Proteostasis Therapeutics reports third quarter 2020 financial results
Aug 06,2020: Proteostasis Therapeutics reports second quarter 2020 financial results
May 15,2020: Proteostasis Therapeutics reports first quarter 2020 financial results and provides corporate update
Mar 10,2020: Proteostasis Therapeutics reports fourth quarter and year-end 2019 financial results and provides corporate update
Jan 22,2020: Proteostasis Therapeutics announces keystone symposia presentation of organoid study from more than 300 adult CF patients

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Yumanity Therapeutics Inc – Key Facts
Yumanity Therapeutics Inc – Key Employees
Yumanity Therapeutics Inc – Key Employee Biographies
Yumanity Therapeutics Inc – Major Products and Services
Yumanity Therapeutics Inc – History
Yumanity Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Yumanity Therapeutics Inc – Business Description
Yumanity Therapeutics Inc – Corporate Strategy
Yumanity Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Yumanity Therapeutics Inc – Strengths
Yumanity Therapeutics Inc – Weaknesses
Yumanity Therapeutics Inc – Opportunities
Yumanity Therapeutics Inc – Threats
Yumanity Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Yumanity Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yumanity Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yumanity Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 16, 2020: Proteostasis Therapeutics reports third quarter 2020 financial results
Aug 06, 2020: Proteostasis Therapeutics reports second quarter 2020 financial results
May 15, 2020: Proteostasis Therapeutics reports first quarter 2020 financial results and provides corporate update
Mar 10, 2020: Proteostasis Therapeutics reports fourth quarter and year-end 2019 financial results and provides corporate update
Jan 22, 2020: Proteostasis Therapeutics announces keystone symposia presentation of organoid study from more than 300 adult CF patients
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Yumanity Therapeutics Inc, Key Facts
Yumanity Therapeutics Inc, Key Employees
Yumanity Therapeutics Inc, Key Employee Biographies
Yumanity Therapeutics Inc, Major Products and Services
Yumanity Therapeutics Inc, History
Yumanity Therapeutics Inc, Key Competitors
Yumanity Therapeutics Inc, Ratios based on current share price
Yumanity Therapeutics Inc, Annual Ratios
Yumanity Therapeutics Inc, Annual Ratios (Cont...1)
Yumanity Therapeutics Inc, Interim Ratios
Yumanity Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yumanity Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yumanity Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Yumanity Therapeutics Inc (YMTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Semperit AG Holding (SEM):企業の財務・戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a developer, manufacturer and marketer of rubber products for the medical and industrial sectors. The company’s products include surgical gloves, examination gloves, disposable protective gloves and reusable protective gloves. It also offers hydraulic hoses, …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Tulmar Safety Systems Inc.:企業の戦略・SWOT・財務情報
    Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary Tulmar Safety Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ei Towers SpA:企業の戦略・SWOT・財務情報
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Olink Proteomics AB:医療機器:M&Aディール及び事業提携情報
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • SK Innovation Co., Ltd.:企業のM&A・事業提携・投資動向
    SK Innovation Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SK Innovation Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hankook Tire & Technology Co Ltd (161390):企業の財務・戦略的SWOT分析
    Hankook Tire & Technology Co Ltd (161390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Oriental Hotels Ltd:企業の戦略・SWOT・財務分析
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Africa Oil Corp (AOI):企業の財務・戦略的SWOT分析
    Summary Africa Oil Corp (AOC) is an oil and gas company that discovers, develops, explores and produces oil and gas assets. The company has oil discoveries in Ekales, Agete, Amosing, Ewoi wells in the Lokichar Basin, and others. It owns and operates various blocks including block 9, block 10A, block …
  • Talisman Mining Ltd (TLM):企業の財務・戦略的SWOT分析
    Summary Talisman Mining Ltd (Talisman Mining) is a mining and mineral exploration and development company. The company explores for copper-gold, base metal, and gold deposits. Its projects portfolio includes Springfield project, Sinclair Nickel Project, Milgun Project, Halloween and Halloween West J …
  • eircom Holdings (Ireland) Ltd:企業の戦略・SWOT・財務情報
    eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report Summary eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sanshin Electronics Co., Ltd.:企業の戦略・SWOT・財務分析
    Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EnBW Energie Baden-Wurttemberg AG (EBK):石油・ガス:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Philippine Long Distance Telephone Co (TEL):企業の財務・戦略的SWOT分析
    Philippine Long Distance Telephone Co (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Technip SA (TEC)-石油・ガス分野:企業M&A・提携分析
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • Gilat Satellite Networks Ltd. (GILT):企業の財務・戦略的SWOT分析
    Gilat Satellite Networks Ltd. (GILT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Banca Dello Stato Del Cantone Ticino:企業の戦略・SWOT・財務分析
    Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report Summary Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Koninklijke Philips N.V. (PHIA)-エネルギー分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Pro Petroleum Inc:企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆